Literature DB >> 20853610

[The basic properties of mesenchymal stromal cells from the donor bone marrow: superficial markers].

D A Svinareva, I N Shipunova, Iu V Ol'shanskaia, K S Momotiuk, N I Drize, V G Savchenko.   

Abstract

AIM: To characterize a superficial phenotype and to make a cytogenetic analysis of bone marrow (BM) mesenchymal stromal cells (MSC) from donors.
MATERIALS AND METHODS: The study analyzed BM samples from 11 healthy donors. The phenotype of obtained MSC was analyzed using cytofluorometry. Chromosomal analysis was carried out at the first-second passage.
RESULTS: The superficial phenotype of MSC was steady-state during 8 passages and conformed to the worldwide standard for this cell population. The marker NGFR+ was detectable only during the first 2 passages and the count of CD146+ cells was decreased to 50% as consecutive passages were carried out, which confirms that MSCs have lost their neural and endothelial differentiation capacity. MSCs are stably able to differentiate only into the mesenchymal lineage. The detection of chromosomal rearrangements in MSCs at different stages of cultivation revealed no clonal rearrangements in any case. However, chromosomal aberrations were found 3-10% of metaphases at the first and second passages, which may be associated with chromosome instability in primary cultures.
CONCLUSION: The pooled data suggest that the analyzed MSCs meet the conventional worldwide standards.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20853610

Source DB:  PubMed          Journal:  Ter Arkh        ISSN: 0040-3660            Impact factor:   0.467


  4 in total

1.  Long-term survival of donor bone marrow multipotent mesenchymal stromal cells implanted into the periosteum of patients with allogeneic graft failure.

Authors:  L A Kuzmina; N A Petinati; N V Sats; N J Drize; N V Risinskaya; A B Sudarikov; V A Vasilieva; M Y Drokov; E D Michalzova; E N Parovichnikova; V G Savchenko
Journal:  Int J Hematol       Date:  2016-05-12       Impact factor: 2.490

2.  Characterization of long-term in vitro culture-related alterations of human tonsil-derived mesenchymal stem cells: role for CCN1 in replicative senescence-associated increase in osteogenic differentiation.

Authors:  Yeonsil Yu; Yoon Shin Park; Han Su Kim; Ha Yeong Kim; Yoon Mi Jin; Sung-Chul Jung; Kyung-Ha Ryu; Inho Jo
Journal:  J Anat       Date:  2014-08-23       Impact factor: 2.610

3.  Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study.

Authors:  Larisa A Kuzmina; Natalia A Petinati; Elena N Parovichnikova; Lidia S Lubimova; Elena O Gribanova; Tatjana V Gaponova; Irina N Shipounova; Oxana A Zhironkina; Alexey E Bigildeev; Daria A Svinareva; Nina J Drize; Valery G Savchenko
Journal:  Stem Cells Int       Date:  2011-12-25       Impact factor: 5.443

4.  Recovery of Donor Hematopoiesis after Graft Failure and Second Hematopoietic Stem Cell Transplantation with Intraosseous Administration of Mesenchymal Stromal Cells.

Authors:  Nataliya Petinati; Nina Drize; Natalia Sats; Natalya Risinskaya; Andrey Sudarikov; Michail Drokov; Daria Dubniak; Alina Kraizman; Maria Nareyko; Natalia Popova; Maya Firsova; Larisa Kuzmina; Elena Parovichnikova; Valeriy Savchenko
Journal:  Stem Cells Int       Date:  2018-04-10       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.